TABLE 2.
Medians and IQRs of dietary components and BAs among the 2224 participants in ATBC and 986 participants in PLCO
| Study | |||
|---|---|---|---|
| PLCO | |||
| ATBC | Men | Women | |
| Dietary components | |||
| Coffee, cups/d | 2.32 (1.39–3.16) | 1.00 (0.79–2.50) | 1.00 (0.43–2.50) |
| Alcoholic, drinks/d | 1.04 (0.33–2.13) | 0.40 (0.03–1.69) | 0.04 (0.00–0.43) |
| % kcal, fat | 40.09 (36.64–43.81) | 33.72 (28.91–37.91) | 30.10 (26.22–34.78) |
| Saturated fat/1000 kcal/d | 18.50 (15.02–22.27) | 11.26 (9.28–13.22) | 9.98 (8.44–12.09) |
| Trans fat/1000 kcal/d | 1.13 (0.88–1.58) | 2.81 (2.39–3.23) | 2.63 (2.22–3.10) |
| Monounsaturated fat/1000 kcal/d | 12.04 (10.89–13.20) | 12.75 (10.84–14.59) | 11.20 (9.57–12.83) |
| Polyunsaturated fat/1000 kcal/d | 0.80 (0.63–1.01) | 6.49 (5.54–7.61) | 6.26 (5.41–7.17) |
| Fiber/1000 kcal/d | 6.63 (4.67–8.92) | 10.58 (8.91–12.55) | 12.24 (10.24–14.62) |
| Insoluble fiber/1000 kcal/d | 4.02 (3.17–5.03) | 6.68 (5.53–8.16) | 7.82 (6.41–9.56) |
| Soluble fiber/1000 kcal/d | 2.07 (1.71–2.50) | 3.74 (3.24–4.38) | 4.35 (3.61–5.02) |
| BAs | |||
| Cholic acid, ng/mL | 28.40 (12.00–105) | 10.70 (4.12–37.05) | 8.33 (3.19–22.55) |
| Chenodeoxycholic acid, ng/mL | 56.70 (22.50–158) | 34.90 (10.04–94.25) | 21.50 (7.32–72.45) |
| Deoxycholic acid, ng/mL | 88.7 (45.1–160) | 88.65 (35.58–181) | 90.15 (41.27–171) |
| Lithocholic acid, ng/mL | 4.78 (3.51–7.16) | 3.54 (1.50–7.70) | 3.42 (1.54–6.85) |
| Ursodeoxycholic acid, ng/mL | 18.80 (9.81–40.80) | 8.10 (3.33–23.47) | 7.34 (3.04–21.20) |
| Glycocholic acid, ng/mL | 35.80 (18.00–78.35) | 66.80 (30.40–141) | 60.40 (24.80–148) |
| Glycochenodeoxycholic acid, ng/mL | 157 (79.47–327) | 234 (109–484) | 190 (90.80–401) |
| Glycodeoxycholic acid, ng/mL | 39.5 (18.7–83.55) | 83.55 (38.80–204.25) | 95.70 (38.60–218) |
| Glycolithocholic acid, ng/mL | 5.03 (3.40–9.22) | 4.48 (1.39–12.10) | 4.62 (1.55–11.30) |
| Glycoursodeoxycholic acid, ng/mL | 27.60 (13.30–57.60) | 22.25 (9.62–54.68) | 21.40 (8.20–53.60) |
| Taurocholic acid, ng/mL | 7.88 (4.39–16.80) | 6.36 (2.22–16.70) | 8.97 (3.21–25.50) |
| Taurochenodeoxycholic acid, ng/mL | 21.4 (11.7–45.05) | 25.70 (9.54–59.90) | 27.50 (12.20–74.90) |
| Taurodeoxycholic acid, ng/mL | 12.7 (7.77–23.90) | 10.70 (4.33–27.20) | 17.45 (5.67–46.53) |
| Taurolithocholic acid, ng/mL | 3.65 (2.95–5.64) | 1.47 (0.42–3.08) | 1.25 (0.46–2.93) |
| Tauroursodeoxycholic acid, ng/mL | 4.38 (3.17–7.05) | 1.20 (0.43–2.91) | 1.21 (0.39–4.24) |
Abbreviations: ATBC, Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study; BA, bile acid; PLCO, Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.